Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
Home2024 (Page 20)

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the ‘Company’, ‘Sona’) announces results from its most recent preclinical study of its Targeted Hyperthermia Therapy (‘THT’) which uses the Company’s patented, biocompatible gold nanorods (‘GNRs’) to treat certain solid cancer tumors, shrinking them and acting as an